State Bank of India, Bank of India and Bank of Maharashtra have decided to cut lending rates by 25 basis points (bps) from today, making loans cheaper for both existing and new…
Category: BUSINESS
EXPLAINER: Will RBI’s move rein in the gold loan rush? – Banking & Finance News
Shares of leading gold loan financiers have taken a hit after the Reserve Bank of India released draft norms for lending against gold. While non-banking financial companies have downplayed the impact, the…
‘Tariff war can be a catalyst for bilateral trade pacts,’ says Piyush Arora – Industry News
The global tariff war started by the US can make India look favourably at bilateral trade agreements, which would help bring in new global products and the latest technology to the domestic…
Lodhas settle brand name dispute – Industry News
After months of mediation, warring brothers, Abhishek and Abhinandan Lodha have ‘amicably settled’ their dispute over the use of the Lodha brand name. According to a joint statement, Abhishek’s Macrotech Developers (MDL),…
Pharma firms hope for ‘full exemption’ from US reciprocal tariffs – Healthcare News
With the US government giving a 90-day breather on reciprocal tariffs, the domestic pharma sector is expecting complete exemption from tariffs in the near future on the lines of exclusions being given…
Start-up fund 2.0 to ease investor exits, bridge liquidity gaps – Start Ups News
The second edition of the Fund of Funds Scheme (FFS 2.0) for start-ups announced in the Budget FY26 will also support private-sector funds that provide secondary capital to enable exits by early-stage…
M&A, PE deals hit three-year high in January-March – Industry News
Deal activity in the domestic consumer and retail markets rose to a three-year high in the first quarter of calendar year 2025, as investors backed brands that merged tradition with innovation, Grant…
Full rooms, firm rates and a sector in the sun – Industry Insights News
Try booking a hotel in Rishikesh these days. Not during peak season. Just any regular weekend. You’ll probably find a Rs 9,000-a-night room with a river view — but not without a…
Why Pfizer scrapped obesity pill development: Weight-loss drug market – Healthcare News
Pfizer said on Monday it has discontinued development of experimental weight-loss pill danuglipron after a trial patient experienced potential drug-induced liver injury that resolved after the medication was stopped. The company had…